CORMEDIX INC (CRMD) Stock Balance Sheet
NASDAQ:CRMD - Nasdaq - US21900C3088 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 40.65M | 43.64M | 43.15M | 53.32M | 41.91M | |||
| Marketable Securities | 11.04M | 32.39M | 15.64M | 12.15M | 4.44M | |||
| Receivables | 51.65M | N/A | 0.00 | 50.00K | 0.00 | |||
| Inventories | 7.60M | 2.11M | 0.00 | 0.00 | 140.00K | |||
| Other Current Assets | 3.63M | 1.31M | 750.00K | 950.00K | 1.68M | |||
| Total Current Assets | 114.58M | 79.45M | 59.55M | 66.47M | 48.18M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.32M | 2.51M | 2.38M | 2.37M | 1.13M | |||
| Intangibles | 1.84M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 105.40K | 103.10K | 100.00K | 100.00K | N/A | |||
| Total Non-Current Assets | 4.27M | 2.61M | 2.49M | 2.48M | 1.13M | |||
| TOTAL ASSETS | 118.85M | 82.06M | 62.04M | 68.95M | 49.31M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 32.12M | 7.12M | 4.11M | 3.14M | 3.03M | |||
| Accounts Payable | 1.72M | 4.28M | 2.20M | 2.21M | 1.13M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 33.84M | 11.40M | 6.31M | 5.35M | 4.16M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 349.10K | 517.00K | 670.00K | 800.00K | 920.00K | |||
| Total Non-Current Liabilities | 349.10K | 517.00K | 670.00K | 800.00K | 930.00K | |||
| TOTAL LIABILITIES | 34.19M | 11.92M | 6.98M | 6.15M | 5.09M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -339.63M | -321.70M | -275.36M | -245.66M | -217.45M | |||
| Additional Paid In Capital | 424.13M | 391.69M | 330.29M | 308.33M | 261.54M | |||
| Common Shares | 64.60K | 55.10K | 40.00K | 40.00K | 30.00K | |||
| Other Shareholders' Equity | 90.70K | 94.10K | 80.00K | 90.00K | 100.00K | |||
| Shares Outstanding | 64.41M | 54.94M | 42.82M | 38.09M | 33.56M | |||
| Tangible Book Value per Share | 1.29 | 1.28 | 1.29 | 1.65 | 1.32 | |||
| Total Shareholders' Equity | 84.66M | 70.14M | 55.06M | 62.80M | 44.22M | |||
| TOTAL LIABILITIES AND EQUITY | 118.85M | 82.06M | 62.04M | 68.95M | 49.31M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.39 | 6.97 | 9.44 | 12.42 | 11.58 | |||
| Return On Assets (ROA) | -15.09% | -56.47% | -47.87% | -40.91% | -44.68% | |||
| Return On Equity (ROE) | -21.18% | -66.06% | -53.94% | -44.92% | -49.82% | |||
All data in USD , ROIC based on taxRate of 0.21